Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | MMP12 | P39900 | 1/20 | 0.51 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PAM | P19021 | 1/20 | 0.50 |
| ▸ | CACNA1B | Q00975 | 5/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20539359 | 1.00 | MMP1 (0.51) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL9762368 | 0.89 | IDO1 (0.57) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL4315631 | 0.87 | MMP1 (0.49) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL3468078 | 0.87 | CACNA1B (0.50) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL75625 | 0.87 | CACNA1B (0.50) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL75626 | 0.87 | CACNA1B (0.50) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL873964 | 0.87 | MMP1 (0.49) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL873965 | 0.87 | MMP1 (0.49) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL873963 | 0.87 | MMP1 (0.49) | MMP1MMP2MMP9MMP12IDO1 | |
| SCHEMBL12123424 | 0.86 | MMP1 (0.54) | MMP1MMP2MMP9MMP12IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4185883-B1 | METHODS FOR GENERATION OF HYPERPOLARIZED COMPOUNDS USING PARAHYDROGEN | NVISION IMAGING TECH GMBH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4711793-A2 | BROADBAND METHOD FOR SIGNAL AMPLIFICATION OF MAGNETIC RESONANCE CONTRAST AGENTS WITHIN SECONDS AND THEIR PURIFICATION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4711794-A2 | BROADBAND METHOD FOR SIGNAL AMPLIFICATION OF MAGNETIC RESONANCE CONTRAST AGENTS WITHIN SECONDS AND THEIR PURIFICATION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V. (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4674829-A2 | SYSTEM AND METHOD FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVision Imaging Technologies GmbH (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4127752-B1 | SYSTEM AND METHOD FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVISION IMAGING TECH GMBH (DE) | 2025-11-26 | — | — | EP | disclosed |
| US-20250123342-A1 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED COMPOUNDS USING PARAHYDROGEN | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2025-04-17 | — | — | US | disclosed |
| US-20250091980-A1 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2025-03-20 | — | — | US | disclosed |
| US-20250059127-A1 | ADIABATIC RAPID PASSAGE AND SPIN COHERENCE TRANSFER MEDIATES EFFICIENT HYPERPOLARIZATION OF HETERONULCLEI IN PRODUCTS OF HYDROGENATION WITH PARAHYDROGEN | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2025-02-20 | — | — | US | disclosed |
| US-12216185-B2 | Systems and methods for generation of hyperpolarized compounds using parahydrogen | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2025-02-04 | — | — | US | disclosed |
| US-20240353512-A1 | BROADBAND METHOD FOR SIGNAL AMPLIFICATION OF MAGNETIC RESONANCE CONTRAST AGENTS WITHIN SECONDS AND THEIR PURIFICATION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2024-10-24 | — | — | US | disclosed |
| US-20230295058-A1 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED COMPOUNDS USING PARAHYDROGEN | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2023-09-21 | — | — | US | disclosed |
| EP-4185883-A2 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED COMPOUNDS USING PARAHYDROGEN | NVision Imaging Technologies GmbH (DE) | 2023-05-31 | — | — | EP | disclosed |
| US-20230152399-A1 | SYSTEMS AND METHOD FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| WO-2023025950-A1 | BROADBAND METHOD FOR SIGNAL AMPLIFICATION OF MAGNETIC RESONANCE CONTRAST AGENTS WITHIN SECONDS AND THEIR PURIFICATION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2023-03-02 | — | — | WO | disclosed |
| EP-4141464-A1 | BROADBAND METHOD FOR SIGNAL AMPLIFICATION OF MAGNETIC RESONANCE CONTRAST AGENTS WITHIN SECONDS AND THEIR PURIFICATION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-03-01 | — | — | EP | disclosed |
| EP-4127752-A2 | SYSTEMS AND METHOD FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVision Imaging Technologies GmbH (DE) | 2023-02-08 | — | — | EP | disclosed |
| WO-2022200859-A1 | SYSTEMS AND METHOD FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVision Imaging Technolgies GmbH (DE) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022157534-A1 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED COMPOUNDS USING PARAHYDROGEN | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022018514-A2 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED COMPOUNDS USING PARAHYDROGEN | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2022-01-27 | — | — | WO | disclosed |
| WO-2021198776-A2 | SYSTEMS AND METHOD FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVISION IMAGING TECHNOLOGIES GMBH (DE) | 2021-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059127-A1 | ADIABATIC RAPID PASSAGE AND SPIN COHERENCE TRANSFER MEDIATES EFFICIENT HYPERPOLARIZATION OF HETERONULCLEI IN PRODUCTS OF HYDROGENATION WITH PARAHYDROGEN | SPIN4, HNRNPUL2, HNMT | MMP1 2725/4885MMP2 2021/4885MMP9 4515/4885 |
| US-20230152399-A1 | SYSTEMS AND METHOD FOR GENERATION OF HYPERPOLARIZED MATERIALS | HPGD, HPD, GCG | MMP1 2403/4885MMP2 3495/4885MMP9 3140/4885 |
| US-20230295058-A1 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED COMPOUNDS USING PARAHYDROGEN | FH, HAMP, HCN2 | MMP1 4329/4885MMP2 4247/4885MMP9 4495/4885 |
| US-20250091980-A1 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS | GLS2, HNMT, FH | MMP1 3495/4885MMP2 3989/4885MMP9 4312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.